Skip to main content

Table 3 Mean (SEM) baseline clinical scores and baseline kinetic and kinematic variables for subjects in the combined locomotor treadmill training and Tizanidine (TizLTT) and locomotor treadmill training alone (LTT) groups that did and did not achieve the minimal important difference (MID) for walking speed (10MWT)

From: Facilitatory effects of anti-spastic medication on robotic locomotor training in people with chronic incomplete spinal cord injury

Group

TizLTT

LTT

Test

MID achieved

MID not achieved

P-value

MID achieved

MID not achieved

P-value

WISCI II score

18.9 (0.9)

14.3 (1.1)

<0.01

16.0 (3.5)

14.4 (1.2)

0.70

10MWT speed (m/s)

0.8 (0.1)

0.4 (0.1)

0.02

1.1 (0.3)

0.5 (0.1)

0.01

6MWT distance (m)

280.5 (30.8)

154.6 (35.8)

0.02

364.5 (92.8)

171.6 (28.1)

0.02

TUG time (s)

15.0 (1.9)

51.8 (12.5)

0.01

12.1 (3.1)

45.1 (9.5)

0.18

MVIC torque

PF

30.7 (6.3)

30.9 (6.7)

0.98

46.6 (7.9)

25.4 (3.9)

0.09

DF

11.4 (2.2)

11.7 (2.9)

0.94

17.1 (2.7)

11.6 (1.5)

0.16

AROM

54.2 (15.2)

40.2 (8.3)

0.55

48.4 (5.8)

32.9 (3.7)

0.09

Vp

189.4 (42.5)

151.9 (34.0)

0.65

160.7 (30.4)

115.4 (15.9)

0.27

  1. Walking index for spinal cord injury II (WISCI II); 10 meter walk test (10MWT); 6 minute walk test (6MWT); timed up and go (TUG); maximum voluntary isometric contraction (MVIC); plantarflexors (PF); dorsiflexors (DF); active range of motion (AROM) and peak velocity during isokinetic dorsiflexion (Vp).